Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7499)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 10, 2017 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Skroza N, Proietti I, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Tolino E, Zuber S, La Torre G, Potenza C. Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp. World J Clin Oncol 2017; 8(5): 405-411 [PMID: 29067277 DOI: 10.5306/wjco.v8.i5.405] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i5/405.htm |
| Number | Citing Articles |
| 1 |
Alise Balcere, Māra Rone Kupfere, Ingrīda Čēma, Angelika Krūmiņa. Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp. Medicina 2019; 55(4): 92 doi: 10.3390/medicina55040092
|
| 2 |
Ilaria Proietti, Simone Michelini, Alessandra Mambrin, Ersilia Tolino, Nicoletta Bernardini, Alessia Anzalone, Daniela Colapietra, Marco Di Fraia, Vincenzo Petrozza, Natale Porta, Nevena Skroza, Concetta Potenza. Transitory auricular nodules: a peculiar adverse reaction in actinic keratosis field treatment. International Journal of Dermatology 2020; 59(8) doi: 10.1111/ijd.14882
|
| 3 |
S. Karrer, R.A.G. Aschoff, R. Dominicus, G. Krähn‐Senftleben, G.G. Gauglitz, A. Zarzour, N. Kerrouche, R. Chavda, R.‐M. Szeimies. Methyl aminolevulinate daylight photodynamic therapy applied at home for non‐hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany. Journal of the European Academy of Dermatology and Venereology 2019; 33(4): 661 doi: 10.1111/jdv.15422
|
| 4 |
Sonia Segura, Alejandra Gadea, Lara Nonell, Evelyn Andrades, Silvia Sánchez, Ramon Pujol, Inmaculada Hernández-Muñoz, Agustí Toll, Liang Liu. Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel. PLOS ONE 2020; 15(5): e0232146 doi: 10.1371/journal.pone.0232146
|
| 5 |
Eleni Anthony, Karyn Lun, Saxon D. Smith. Full face ingenol mebutate for actinic keratosis: patient perspective. International Journal of Dermatology 2019; 58(1) doi: 10.1111/ijd.14263
|
| 6 |
Lutz Schmitz, Jes B. Hansen, Mike Bastian, Thomas Larsson, Eggert Stockfleth. Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment?. Journal of Dermatological Treatment 2021; 32(4): 411 doi: 10.1080/09546634.2019.1662879
|